Advertisement
U.S. markets open in 7 hours 20 minutes

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
19.37-0.60 (-3.00%)
At close: 04:00PM EDT
19.77 +0.40 (+2.07%)
After hours: 06:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close19.97
Open19.79
Bid21.14 x 1000
Ask21.89 x 800
Day's Range18.96 - 19.96
52 Week Range16.51 - 59.99
Volume1,189,971
Avg. Volume952,930
Market Cap1.164B
Beta (5Y Monthly)0.87
PE Ratio (TTM)N/A
EPS (TTM)-9.05
Earnings DateApr 30, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SAGE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sage Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 11/16/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • Insider Monkey

    25 Most Stressed Cities in the United States

    In this article, we will be taking a look at the 25 most stressed cities in the United States. If you do not want to learn about the global impact of stress and depression, head straight to the 5 Most Stressed Cities in the United States. In the bustling landscape of the United States, certain […]

  • Zacks

    Why Is Sage Therapeutics, Inc. (SAGE) Down 22% Since Last Earnings Report?

    Sage Therapeutics, Inc. (SAGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Business Wire

    Sage Therapeutics to Present at Upcoming March Investor Conferences

    CAMBRIDGE, Mass., February 28, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in March: